Related Experiment Video
Updated: Jul 7, 2026
09:00
A Multi-detection Assay for Malaria Transmitting Mosquitoes
Published on: February 28, 2015
13.6K
Rapid phenotyping towards personalized malaria medicine
Maria Isabel Veiga1,2, Weng Kung Peng3
1Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho, Braga, Portugal.
Malaria Journal
|February 13, 2020
Summary
Nuclear magnetic resonance (NMR) diagnostics offer new hope for malaria detection and personalized treatment. Open-sourcing these point-of-care technologies can accelerate their field implementation to combat malaria.
Area of Science:
- Medical Diagnostics
- Parasitology
- Public Health
Background:
- Malaria remains a significant global health threat, causing over 435,000 deaths annually.
- Drug resistance and difficulty detecting low parasite levels impede malaria eradication efforts by 2030.
- Existing diagnostic methods face challenges in accessibility and speed for effective malaria control.
Purpose of the Study:
- To review recent technological advancements in malaria diagnostics.
- To highlight the potential of nuclear magnetic resonance (NMR)-based technologies for point-of-care malaria diagnosis.
- To explore pathways for integrating these technologies into personalized medicine approaches.
Main Methods:
- Focus on recent publications and technological innovations in malaria diagnostics.
- Analysis of nuclear magnetic resonance (NMR)-based diagnostic technologies.
- Discussion of strategies for bridging the gap between technological development and field application.
Main Results:
- Nuclear magnetic resonance (NMR) based technologies show promise for rapid and sensitive malaria detection.
- Point-of-care diagnostics are crucial for timely intervention and personalized malaria treatment.
- An open-sourcing initiative is proposed to accelerate the adoption of new diagnostic tools.
Conclusions:
- Nuclear magnetic resonance (NMR) diagnostics represent a significant advancement in the fight against malaria.
- Personalized medicine approaches, enabled by advanced diagnostics, are key to overcoming malaria.
- Open collaboration and rapid implementation are essential to achieve the Sustainable Development Goals for malaria eradication.
More Related Videos
Related Concept Videos
01:29Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu
Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...
01:27Pharmacogenetics of Drug Metabolism: Overview
Genetic polymorphism in drug metabolism is crucial to the inter-individual variability observed in drug responses. Drug metabolism primarily involves the chemical modification of drugs and other xenobiotics to enhance their elimination by increasing their polarity. Two main classes of enzymes mediate this biotransformation process: Phase I enzymes, primarily cytochrome P450s, catalyze oxidation and reduction reactions, while other enzymes, such as esterases, mediate hydrolysis, and Phase II...
01:28Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes
Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450 isoenzymes,...
01:29Pharmacogenomics: Identification of New Drug Targets
Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
01:25Rapid Identification of Pathogens
MALDI-TOF MS has transformed clinical microbiology by offering a rapid and reliable method for pathogen identification. The traditional approach to microbial identification typically involves time-consuming culture techniques and biochemical tests, which can delay the initiation of appropriate antimicrobial therapy. MALDI-TOF MS avoids these delays by using characteristic ribosomal protein mass patterns of microbial cells, enabling accurate species-level identification within minutes.Principle...
01:29Malaria
Malaria pathogenesis in humans reflects a delicate interplay between parasite biology and host response. Clinical illness reflects a host’s immune response to the parasite’s asexual replication cycle, which is often asymptomatic in individuals with partial immunity. From the parasite's perspective, transmission between mosquito and human with minimal host pathology is evolutionarily advantageous. Among the six Plasmodium species infecting humans, P. falciparum and P. vivax dominate in global...